News

Search:

FDA Publishes New Benefit-Risk Paradigm Framework, Rejects Quantitative-Only Approach

2 Likes

The US Food and Drug Administration (FDA) has published a new report calling for a new drug regulatory decision-making paradigm for risk-benefit assessments, rejecting calls for a quantitative-only Read More...

Tags:

Benefit

Benefit-risk

BLA

FDA

framework

NDA

Risk

Risk/Benefit

CDRH Releases New Training Module for Guidance on Benefit-Risk Determinations

0 Likes

The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) released a new training module on a guidance document released by the agency that focuses on making Read More...

Tags:

Application

Benefit:Risk

Benefit-risk

CDRH

De Novo

Education

FDA

Guidance

Learn

Module

PMA

Risk/Benefit

Training

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Related News

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

FDA Publishes New Benefit-Risk Paradigm Framework, Rejects Quantitative-Only Approach

CDRH Releases New Training Module for Guidance on Benefit-Risk Determinations

Get RF Today